VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...

Sharps Technology Inc. (NASDAQ: STSS) is an innovative medical device and pharmaceutical packaging company that seems positioned for growth through its commercial-ready, patented copolymer syringe ...

Sharps Technology Inc. STSS is an innovative medical device and pharmaceutical packaging company that seems positioned for growth through its commercial-ready, patented copolymer syringe products. The ...